AST SpaceMobile stock: BlueBird 7 satellite lost, what happens next for ASTS investors

AST SpaceMobile (Nasdaq: ASTS) has confirmed the total loss of its BlueBird 7 satellite after Blue Origin’s New Glenn rocket placed the spacecraft into a fatally low orbit during today’s NG-3 mission from Cape Canaveral. The satellite separated from the launch vehicle and powered on successfully, but the New Glenn upper stage delivered it into a 154 by 494 kilometre orbit at 36.1 degrees inclination, far below its operational target. AST SpaceMobile confirmed the altitude was too low for the onboard thruster technology to compensate, and BlueBird 7 will now be deorbited to burn up in the atmosphere. The company said the satellite’s cost is covered by its insurance policy, and that production of BlueBird 8 through BlueBird 10 remains on track with delivery expected within approximately 30 days.

What does AST SpaceMobile do and why is this loss more than just a bad launch day?

AST SpaceMobile is building the first space-based cellular broadband network designed to work with standard, unmodified smartphones, no special hardware required. Every BlueBird satellite is, in effect, a cellular tower in low Earth orbit, covering territory that no ground-based network reaches. The company’s business model is built around licensing this coverage to mobile network operators including AT&T and Verizon, who then deliver it to their customers as a seamless extension of their terrestrial networks.

The technology that makes this possible is a proprietary application-specific integrated circuit called the AST5000, which drives a phased array antenna spanning approximately 2,400 square feet on each Block 2 BlueBird. That is the largest commercial communications array ever deployed in low Earth orbit. The sheer scale of the antenna is what allows the satellite to capture the weak signal of a standard handset 500 kilometres below, a physics problem no other commercial operator has solved at this antenna aperture.

Today’s loss matters beyond the individual satellite because the entire commercial thesis is built on a specific number: 45 to 60 Block 2 BlueBirds in orbit by end of 2026. That count is what unlocks continuous coverage over the continental United States and the other initial service markets. BlueBird 7 was intended to become the eighth satellite in the constellation, and its loss means the company must now recover that slot through faster production and an additional successful launch. With Blue Origin’s New Glenn now undergoing an anomaly investigation following its first upper stage failure, the immediate launch cadence question is whether the NG-3 investigation grounds subsequent New Glenn missions and how long that standdown lasts.

What exactly went wrong on the New Glenn NG-3 mission and who is responsible?

The NG-3 launch appeared nominal through first stage separation and booster recovery. The first stage, nicknamed “Never Tell Me the Odds” and being flown for the first time on a reused basis, lifted off at approximately 7:35 a.m. EDT and performed a successful landing on Blue Origin’s recovery vessel in the Atlantic Ocean. The failure was entirely in the upper stage. US Space Force tracking data confirmed the orbit achieved was 154 by 494 kilometres, the result of the upper stage’s additional burns to raise the orbit not achieving their planned parameters.

Blue Origin confirmed the off-nominal orbit and stated it is assessing the anomaly. The company was launching commercial payloads on just its third New Glenn mission, a decision that drew comparisons today to SpaceX’s early Falcon 9 program, which also lost payloads mid-program before achieving the reliability that now defines it. SpaceX lost an International Space Station resupply cargo spacecraft on its 19th Falcon 9 mission in 2015, and a Meta internet satellite in a 2016 pad explosion, before the rocket became the most flown orbital vehicle in history.

The liability question matters for AST SpaceMobile’s timeline. The company has a multi-launch agreement with Blue Origin for subsequent BlueBird deliveries, with New Glenn capable of carrying up to eight Block 2 satellites per mission. If Blue Origin grounds New Glenn pending investigation, as launch providers typically do after anomalies, those manifested payloads will need to shift to alternative providers. AST SpaceMobile has existing launch relationships with SpaceX Falcon 9 and India’s ISRO LVM3, and has indicated that its 2026 launch plan is supported by agreements with multiple providers. The degree to which it can absorb a New Glenn standdown without slipping the year-end constellation target is the central operational question now facing the company.

How does AST SpaceMobile’s production pipeline absorb the BlueBird 7 loss?

The financial and operational damage from BlueBird 7, while real, is more contained than the initial market reaction may suggest. Insurance coverage for the lost satellite removes the most immediate balance sheet impact, and the company’s manufacturing operation in Midland, Texas is well ahead of the launch cadence. As of the latest company update, BlueBird 8 through BlueBird 10 are expected to be ready to ship within approximately 30 days, and production is currently running through BlueBird 32. The company has over 500,000 square feet of manufacturing space globally following the addition of a fourth Midland site.

The production pipeline data is material for investors assessing the recovery. If BlueBird 7 can be effectively replaced by an additional launch of a production-ready satellite within two to three months, the constellation count by year-end still reaches the 45-satellite threshold, though with reduced margin for additional delays. If the New Glenn investigation extends beyond six to eight weeks, the maths begin to tighten. The company has previously guided to one to two launches per month on average across the full year, explicitly relying on New Glenn booster reuse at a 30-day turnaround. That reuse cadence is now in question.

AST SpaceMobile’s full-year 2025 revenue was USD 70.9 million, a 641 percent increase year on year, driven by gateway hardware deliveries and US government contract milestones. The company held over USD 3.9 billion in liquidity at year-end 2025 and has more than USD 1.2 billion in contracted revenue commitments from partners including AT&T, Verizon, and Saudi Arabia’s stc. The financial position provides runway to absorb setbacks, but the stock’s premium valuation was built on a deployment schedule that now faces its first confirmed failure.

Why do AT&T and Verizon remain the commercial anchor that keeps the ASTS thesis intact despite this setback?

The carrier agreements represent the most durable part of the AST SpaceMobile investment case and they have not changed today. AT&T signed a binding six-year direct-to-device commercial agreement and has been publicly building out the ground gateway infrastructure to support it, with four gateways online in the US as of early 2026. Verizon signed its definitive commercial agreement in October 2025 converting a USD 100 million strategic investment into a contractual commitment to launch service for Verizon customers. Both carriers have successfully completed voice-over-LTE calls and data tests through the existing BlueBird constellation.

The strategic logic driving both carriers is as important as the contracts themselves. T-Mobile has an exclusivity deal with SpaceX’s Starlink for its D2D offering and has been aggressive in marketing free satellite connectivity to its customers while charging AT&T and Verizon subscribers USD 10 per month for the same. AT&T and Verizon need AST SpaceMobile to work because allowing SpaceX to own the D2D infrastructure that all American carriers depend on would hand Elon Musk structural leverage over the US wireless industry. That competitive imperative does not change because of an upper stage anomaly on a Blue Origin rocket.

The near-term commercial activation sequence remains AT&T’s FirstNet service, a satellite connectivity layer for the more than 12 million US first responders who use the network. Beta service on FirstNet was targeted for the first half of 2026, supported by the existing operational BlueBird constellation of seven satellites. That window may slip depending on coverage density assessments, but it does not depend on BlueBird 7 specifically.

How does the Amazon-Globalstar deal this week interact with today’s launch failure?

AST SpaceMobile enters Monday’s trading session carrying the weight of two significant negative headlines in a single week. Amazon’s USD 11.57 billion acquisition of Globalstar, announced on April 14 and 15, already triggered selling pressure as investors assessed a newly crowded D2D market. Today’s BlueBird 7 loss adds an execution risk narrative on top of the competitive narrative, a combination that typically weighs on high-valuation, pre-profit technology stocks in the short term.

The Amazon deal confirmed that direct-to-device satellite connectivity is a large enough market that the world’s largest technology company by distribution is willing to deploy over USD 11 billion to enter it. That is simultaneously a validation of the category and a signal that the window to establish position before deep-pocketed competition arrives is narrowing. FCC Chair Brendan Carr explicitly named SpaceX, Amazon, and AST SpaceMobile as the three players in what he called a healthy competitive satellite-to-phone market. Being named in that trio is a form of institutional endorsement, but it also confirms that AST SpaceMobile is no longer operating in a niche with limited scrutiny.

The bear case this week argues that AST SpaceMobile is executing a multi-year, capital-intensive constellation build against opponents who are either already in orbit at scale or arriving with far greater financial firepower, and that today’s launch failure is a preview of the execution risk embedded in a stock trading at USD 32 to 35 billion market capitalisation on USD 70.9 million of annual revenue. The bull case argues that the satellite is insured, production is running through BlueBird 32, the carrier contracts are binding, and Blue Origin anomalies are recoverable as SpaceX’s own history demonstrates. Both cases are legitimate and the stock will likely reflect the tension between them through the week.

What does the retail investor community need to watch over the next 30 to 60 days?

The catalysts that will determine whether today’s setback is a speed bump or a schedule inflection point are specific and dateable. First, Blue Origin’s anomaly investigation timeline: the company will need to characterise what caused the New Glenn upper stage to deliver the wrong orbit before it can return to flight, and any public update on the investigation duration will directly affect ASTS’s constellation delivery timeline. Second, the shift of manifested BlueBird payloads to alternative launch providers: if AST SpaceMobile announces a Falcon 9 booking or an additional LVM3 slot within the next 30 days, it signals that the company is actively managing around the New Glenn disruption. Third, the insurance confirmation: an explicit company statement on the insurance payout timeline will remove the capital uncertainty from the BlueBird 7 loss.

The May 18, 2026 earnings call is the most important near-term event for investors. CEO Abel Avellan and President Scott Wisniewski will be expected to provide a revised constellation timeline that accounts for the BlueBird 7 loss, an update on the launch provider relationship with Blue Origin, and any updated guidance on the commercial service activation date with AT&T. A credible path to 45 satellites by year-end that does not depend exclusively on New Glenn would likely stabilise the stock. A vague or defensive response would accelerate selling.

ASTS is a high-beta stock with a history of sharp moves in both directions on news. The 52-week range of USD 20.26 to USD 129.89 reflects a market that has regularly repriced the company by 20 to 30 percent in a week. Today’s loss adds a new layer of uncertainty but does not change the fundamental commercial architecture. Investors already positioned in ASTS should assess not whether the thesis is broken, but whether the execution timeline has shifted materially, and whether the current market capitalisation adequately prices that delay.

Key takeaways for ASTS investors after today’s BlueBird 7 loss

• BlueBird 7 is a confirmed total loss. The New Glenn upper stage placed the satellite into an orbit too low for onboard thrusters to correct, and the satellite will be deorbited. The cost is covered by AST SpaceMobile’s insurance policy.
• The failure was a Blue Origin upper stage anomaly, not an AST SpaceMobile manufacturing or satellite failure. BlueBird 7 separated successfully, powered on, and its hardware functioned as designed. Blue Origin is now conducting an anomaly investigation.
• Production is ahead of the launch cadence. BlueBird 8 through BlueBird 10 are expected to be ready to ship within 30 days, and production is running through BlueBird 32. The company still targets approximately 45 satellites in orbit by end of 2026.
• The New Glenn standdown duration is the key near-term variable. AST SpaceMobile has multi-launch agreements with SpaceX Falcon 9 and ISRO LVM3 as alternatives, but any extended Blue Origin grounding creates pressure on the year-end satellite count.
• Carrier agreements with AT&T and Verizon remain intact, as does the USD 1.2 billion-plus contracted revenue backlog. The commercial thesis has not changed; the execution timeline has absorbed a setback.
• The Amazon-Globalstar deal and today’s launch failure together create a particularly challenging week for ASTS. The May 18 earnings call is the next major forum for management to address both developments.
• ASTS is a pre-profit, high-beta execution story. The stock’s valuation assumes successful constellation build-out on a specific timeline. Any credible evidence of timeline slip at the May 18 call will be treated as a material negative by the market.